Profile data is unavailable for this security.
About the company
Nicox SA is a France-based international ophthalmic company. It is engaged in the field of the research, development and future commercialization of investigational drugs for ophthalmological diseases. The Company’s aim is to build a portfolio of therapeutic products addressing the needs of eye care practitioners and patients. Nicox SA offers its customers the Xailin range of ocular lubricants and AdenoPlus, a diagnostic test that aids in the differential diagnosis of acute conjunctivitis. The Company has also products in the pipeline, such as VESNEO (a drug-candidate for treating glaucoma) and AC-170 (for allergic conjunctivis). It has a direct commercial presence in Germany, France, the United Kingdom, Italy and Spain, as well as partnerships with local distributors in a number of key international markets.
- Revenue in EUR (TTM)3.32m
- Net income in EUR-27.06m
- Incorporated1996
- Employees11.00
- LocationNicox SADrakkar 2 - Batiment D2405 route des DolinesCS 10313 Sophia AntipolisBIOT 06410FranceFRA
- Phone+33 497245300
- Fax+33 497245399
- Websitehttps://www.nicox.com
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Malin Corporation plc | 0.00 | 0.00 | 33.31m | 2.00 | -- | 0.7463 | 328.79 | -- | 0.00 | 0.00 | 0.00 | 10.18 | 0.00 | -- | -- | 0.00 | 0.00 | 8.14 | 0.00 | 8.56 | -- | -- | -- | -- | -- | -- | 0.00 | 0.00 | -- | -- | -- | -- | -- | -- |
| Rockwell Medical Inc | 63.68m | -4.61m | 33.53m | 244.00 | -- | 1.08 | -- | 0.5266 | -0.1583 | -0.1583 | 2.20 | 0.9395 | 1.32 | 12.92 | 8.78 | 309,741.80 | -9.63 | -32.92 | -12.15 | -46.61 | 15.81 | 8.00 | -7.30 | -23.86 | 3.50 | -6.13 | 0.2141 | -- | 21.38 | 10.61 | 94.31 | -- | 11.47 | -- |
| Decibel Cannabis Company Inc | 67.63m | 7.62m | 33.92m | -- | 3.60 | 0.8619 | 2.83 | 0.5015 | 0.0264 | 0.025 | 0.198 | 0.1102 | 0.795 | 2.15 | 6.51 | -- | 8.96 | -0.0401 | 13.94 | -0.0595 | 21.98 | 20.03 | 11.27 | -0.0688 | 0.6086 | -5.57 | 0.4186 | -- | -12.89 | 71.51 | 810.61 | -- | -4.74 | -- |
| Kohjin Bio Co Ltd | 28.00m | 3.08m | 34.07m | 167.00 | 11.00 | 1.04 | 6.49 | 1.21 | 109.06 | 109.06 | 992.83 | 1,157.47 | 0.5768 | 3.51 | 4.58 | 30,386,960.00 | 6.34 | -- | 8.73 | -- | 43.01 | -- | 10.98 | -- | 1.49 | -- | 0.2443 | -- | 9.14 | -- | 106.44 | -- | -- | -- |
| Eastwood Bio-Medical Canada Inc | 367.87k | -254.81k | 34.10m | -- | -- | -- | -- | 92.69 | -0.006 | -0.006 | 0.0086 | -0.0225 | 2.17 | -- | 26.00 | -- | -150.26 | -71.29 | -- | -- | 63.91 | 56.40 | -69.27 | -57.09 | -- | -31.24 | -- | -- | -19.11 | -11.50 | 16.60 | -- | -- | -- |
| Hin Sang Group (Interntnl) Hldng Co Ltd | 10.30m | -4.32m | 34.13m | 185.00 | -- | 2.08 | -- | 3.09 | -0.0367 | -0.0367 | 0.0875 | 0.1299 | 0.1679 | 2.42 | 12.62 | 459,278.80 | -7.03 | -5.77 | -13.64 | -8.41 | 67.28 | 58.19 | -41.89 | -36.55 | 0.0735 | -0.3333 | 0.7032 | -- | -0.7882 | -12.21 | -34.48 | -- | -50.36 | -- |
| NicOx SA | 3.32m | -27.06m | 34.23m | 11.00 | -- | -- | -- | 10.99 | -0.3657 | -0.3657 | 0.045 | -0.0659 | 0.1034 | -- | 1.63 | 663,166.00 | -84.36 | -28.03 | -91.95 | -30.66 | -- | -- | -816.13 | -338.04 | -- | -56.80 | 1.48 | -- | 13.85 | 2.77 | -7.22 | -- | -- | -- |
| Rhone Ma Holdings Bhd | 45.70m | 2.92m | 34.34m | 205.00 | 15.14 | 0.8544 | 8.58 | 0.7198 | 0.0449 | 0.0449 | 0.7037 | 0.7959 | 0.8988 | 2.29 | 5.19 | -- | 5.87 | 6.05 | 7.20 | 7.35 | 30.65 | 27.97 | 6.53 | 6.64 | 2.05 | 17.24 | 0.1002 | 36.65 | 4.17 | 12.17 | 1.87 | 7.34 | -37.84 | 20.11 |
| Holder | Shares | % Held |
|---|---|---|
| Erasmus Gestion SASas of 03 Sep 2024 | 190.00k | 0.22% |
| Andbank Wealth Management SGIIC SAUas of 31 Dec 2025 | 43.30k | 0.05% |
